Reliability and Validity of Turkish Version of the Diabetes Education Questionnaire (DATE-Q)
February 4, 2025 updated by: Buket AKINCI, Biruni University
Evaluation of Validity and Reliability of the Turkish Version of the Diabetes Education Questionnaire (DATE-Q) in Patients with Diabetes
The Diabetes Education Questionnaire (DATE-Q) is a questionnaire that includes comprehensive care components of diabetes management and specifically questions the effect of exercise on blood glucose levels and the knowledge of the correct exercise intensity in patients with diabetes.
It can be easily and rapidly applied.
The aim of this study is to evaluate the translation into Turkish, validity and reliability of the DATE-Q, which questions the knowledge of diabetic patients about their disease.
Study Overview
Study Type
Observational
Enrollment (Actual)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
İstanbul, Turkey
- Biruni Üniversitesi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients who are diagnosed with Diabetes
Description
Inclusion Criteria:
. Age of 18 or above
- Those whose native language is Turkish
- Volunteer to participate in the study
Exclusion Criteria:
- Individuals who cannot cooperate (those who score below 24 points according to the Standardized Mini Mental Test)
- Those who have problems understanding and speaking Turkish
- Any visual or cognitive disorder that would prevent the participant from answering the survey
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diabetes Education Questionnaire (DATE-Q)
Time Frame: Day 1
|
The Diabetes Education Questionnaire (DATE-Q) is a questionnaire that includes comprehensive care components of diabetes management and specifically questions the effect of exercise on blood glucose levels and the knowledge of the correct exercise intensity in patients with diabetes.
The questionnaire was designed to be a true/false/I don't know questionnaire, with 20 items (four in each domain).
With each correct answer as 1 point, the maximum score possible is 20 overall, 4 by domain.
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 23, 2024
Primary Completion (Actual)
October 23, 2024
Study Completion (Actual)
January 31, 2025
Study Registration Dates
First Submitted
August 24, 2024
First Submitted That Met QC Criteria
August 24, 2024
First Posted (Actual)
August 27, 2024
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 4, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024/1193
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.